Health and Medicine
-
February 13, 2014
VUMC’s Ho honored with presidential research award
Vanderbilt University Medical Center’s Richard Ho, M.D., MSCI, has received a presidential honor for his innovative studies of mechanisms by which drug transporter proteins mediate the absorption, distribution and elimination of chemotherapeutic agents. -
February 13, 2014
Ozier to direct human research protection efforts
Julie Ozier, MHL, has been named director of Vanderbilt’s Human Research Protection Program (HRPP) and Institutional Review Board (IRB). Ozier has worked with the HRPP and IRB for 11 years, has been associate director since 2007, and at Vanderbilt since 1996. -
February 12, 2014
Obesity sends immune cells to the brain
Obesity causes peripheral immune cells to move to the brain, where they may contribute to inflammation and the pathophysiology of obesity. -
February 10, 2014
Keeping the beat after heart surgery
Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery. -
February 7, 2014
New direction for treating lung cancer
Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer. -
February 6, 2014
Hydrocephalus treatment study began in Uganda
Rob Naftel, M.D., traveled more than 8,000 miles to learn a new surgical technique to treat hydrocephalus, the buildup of cerebrospinal fluid in the brain. -
February 6, 2014
Antioxidants promising for rare disorder
The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.